Effects of hyperglycemia and hyperinsulinemia on the tissue factor pathway of blood coagulation

Current Diabetes Reports

Volumn 7, Issue 3, 2007, Pages 223-227

  Boden, Guenther ^a   Rao, A Koneti ^b  

^a TEMPLE UNIVERSITY HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; CD40 LIGAND; GLUCOSE; INSULIN; MESSENGER RNA; SOMATOSTATIN; THROMBIN; THROMBOPLASTIN;

ATHEROGENESIS; BLOOD CELL; BLOOD CLOTTING; CELL TRANSPLANTATION; CELLULAR DISTRIBUTION; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOSIS;

BLOOD COAGULATION; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERGLYCEMIA; HYPERINSULINISM; SOMATOSTATIN; THROMBOPLASTIN;

EID: 34250768930     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-007-0035-1     Document Type: Review

References (31)

1. Pan WH, Cedres LB, Liu K, et al.: Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol 1986, 123:504-516.
2. Uusitupa MI, Niskanen LK, Siitonen O, et al.: 5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects. Circulation 1990, 82:27-36.
3. Kannel WB, D'Agostino RB, Wilson PW, et al.: Diabetes, fibrinogen and risk of cardiovascular disease: the Framingham experience. Am Heart J 1990, 120:672-676.
4. Laakso M, Lehto S: Epidemiology of macrovascular disease in diabetes. Diabetes Rev 1997, 5:294-315.
5. Virmani R, Kolodgie FD, Burke AP, et al.: Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Artherioscler Thromb Vasc Biol 2000, 20:1262-1275.
6. Osterman H, van de Loo J: Factors of the hemostatic system in diabetic patients. Haemostasis 1986, 16:386-416.
7. Kwaan HC: Changes in blood coagulation, platelet function, and plasminogen-plasmin system in diabetes. Diabetes 1992, 41(suppl 2):32-35.
8. Kario K, Mastuo T, Kobayashi H, et al.: Activation of tissue factor-induced coagulation and endothelial cell dysfunction in non-insulin-dependent diabetic patients and microalbuminuria. Arterioscler Thromb Vasc Biol 1995, 15:1114-1120.
9. Morishita E, Asakura H, Jakaji H, et al.: Hypercoagulability and high lipoprotein (a) levels in patients with type II diabetes mellitus. Atherosclerosis 1996, 120:7-14.
10. Jones RL: Fibrinopeptide-A in diabetes mellitus. Relation to levels of blood glucose, fibrinogen disappearance, and hemodynamic changes. Diabetes 1985, 34:836-843.
11. Ceriello A, Giugliano D, Quatraro A, et al.: Blood glucose may condition factor VII levels in diabetic and normal subjects. Diabetologia 1988, 31:889-891.
12. Rao AK, Chouhan V, Chen X, et al.: Activation of the tissue factor pathway of blood coagulation during prolonged hyperglycemia in young healthy men. Diabetes 1999, 48:1156-1161.
13. Rauch U, Nernerson Y: Tissue factor, the blood, and the arterial wall. Trends Cardiovasc Med 2000, 10:139-143.
14. Mackman N: Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol 2004, 24:1015-1022.
15. Wilcox JN, Smith KM, Schwartz SM, Gordon D.: Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A 1989, 86:2839-2843.
16. Giesen PLA, Rauch U, Bohrmann B, et al.: Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A 1999, 96:2311-2315.
17. Key NS, Slungaard A, Dandelet L, et al.: Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease. Blood 1998, 91:4216-4223.
18. Chou J, Mackman N, Merrill-Skoloff G, et al.: Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood 2004, 104:3190-3197.
19. Vaidyula VR, Rao AK, Mozzoli M, et al.: Effects of hyperglycemia and hyperinsulinemia on circulating tissue factor rocoagulant activity and platelet CD40 ligand. Diabetes 2006, 55:202-208.
20. Boden G, Vaidyula VR, Homko C, et al.: Differential effects of somatostatin on circulating tissue factor procoagulant activity and protein. Amer J Physiol Endocrinol Metab 2007, In press.
21. Peluso G, Petillo O, Melone MA, et al.: Modulation of cytokine production in activated human monocytes by somatostatin. Neuropeptides 1996, 30:443-451.
22. Niedermuhlbichler M, Wiedermann CJ: Suppression of superoxide release from human monocytes by somatostatin-related peptides. Regul Pept 1992, 41:39-47.
23. Vaidyula VR, Boden G, Rao AK: Platelet and monocyte activation of hyperglycemia and hyperinsulinemia in healthy subjects. Platelets 2006, 17:577-586.
24. Abdel-Hafiz E, Vaidyula VR, Bagga S, et al.: Elevated whole blood tissue factor procoagulant activity in diabetes mellitus. Vitamin E inhibits glucose induced tissue factor activity in vitro [abstract]. Blood 2002, 100:496a.
25. Sambola A, Osende J, Hathcock J, et al.: Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity. Circulation 2003, 107:973-977.
26. Johansson H, Lukinius A, Moberg L, et al.: Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes 2005, 54:1755-1762.
27. Moberg L, Johansson H, Lukinuis A, et al.: Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 2002, 360:2039-2045.
28. Peppelenbosch MP, Spek CA: Type I diabetes: a role for tissue factor in pancreatic islet transplantation? Lancet 2002, 360:1999-2000.
29. Shapiro AM, Lakey JR, Rajotte RV, et al.: Portal vein thrombosis after transplantation of partially purified pancreatic islets in a combined human liver/islet allograft. Transplantation 1995, 59:1060-1063.
30. Froberg MK, Leone JP, Jessurun J, Sutherland DE: Fatal disseminated intravascular coagulation after autologous islet transplantation. Hum Pathol 1997, 28:1295-1298.
31. Vaidyula VR, Abdel-Hafiz E, Bagga S, et al.: Inhibition of expression of tissue factor procoagulant activity by antiplatelet agents clopidogrel, aspirin and cilostazol in patients with peripheral arterial disease. Thromb Haemost 2006, 96:738-743.